FDA Adverse Event Malfunction Summary report: N

BINAXNOW COVID-19 ANTIGEN SELF-TEST

MDR report key: 15243205 · Received August 17, 2022

Report

Report Number
1221359-2022-03586
Event Type
Malfunction
Date Received
August 17, 2022
Date of Event
August 10, 2022
Report Date
August 10, 2022
Manufacturer
ABBOTT DIAGNOSTICS SCARBOROUGH, INC
Product Code
QKP
UDI-DI
00811877011408
PMA / PMN Number
EUA210264
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
US
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 0

TESTED THE BINAXNOW COVID-19 AG CARD RETAIN KIT LOT 193019 WITH COVID-19 LOD AND BLANK PATIENT SWABS. ALL TESTS WERE RUN IN TRIPLICATE, WERE VALID, AND PERFORMED AS EXPECTED. NO FALSE NEGATIVE RESULTS WERE OBSERVED, AND THE CUSTOMERS COMPLAINT WAS NOT REPLICATED. THE MANUFACTURING RECORDS AND QUALITY CONTROL RELEASE TESTING WAS REVIEWED FOR KIT PART NUMBER 195-160 & 195-260 / LOT 193019 AND DEVICE PART NUMBER 195-430H / LOT 189791. QUALITY CONTROL RELEASE TESTING MET SPECIFICATIONS AND THERE WERE NO FALSE NEGATIVE RESULTS OBSERVED. THE CURRENT OVERALL INCIDENT RATE FOR FALSE NEGATIVE PATIENT RESULTS (CONFIRMED AND UNCONFIRMED, CONFLICTING RESULTS) FOR THIS SPECIFIC LOT BASED ON THE TOTAL QUANTITY OF DEVICES MANUFACTURED FOR DISTRIBUTION IS (B)(4). BASED ON THE EVIDENCE AVAILABLE, IT INDICATES THAT THIS DEVICE LOT IS PERFORMING WITHIN LABEL CLAIMS. NO FURTHER ACTION IS REQUIRED.

Description of Event or Problem · 0

THE CONSUMER REPORTED A FALSE NEGATIVE RESULT WITH THE BINAXNOW COVID-19 ANTIGEN SELF TEST PERFORMED ON (B)(6) 2022 WITH A NASAL SAMPLE. PCR TESTING WAS PERFORMED ON (B)(6) 2022 AND GENERATED A POSITIVE RESULT. THE CONSUMER STATED THAT SHE WAS SYMPTOMATIC. NO ADDITIONAL PATIENT INFORMATION, INCLUDING TREATMENT AND OUTCOME, WAS PROVIDED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1950082 BINAXNOW COVID-19 ANTIGEN SELF-TEST LATERAL FLOW IMMUNOASSAY IVD OF COVID-19 QKP ABBOTT DIAGNOSTICS SCARBOROUGH, INC 193019 00811877011408

Patients

Seq Age Sex Outcome Treatment
1 63 YR Female